Therefore, the aim of our study was to assess the distribution of genetic polymorphisms in genes encoding Nrf2, as regulatory, and SOD2, GPX1, GPX3, and GSTP1 haplotype as catalytic antioxidant proteins in COVID-19 patients and respective controls, with special emphasis on their association with laboratory biochemical parameters. This evidence concerns the gene GPX1 and COVID-19.